• Return to Headlines

Revance Therapeu Has Returned 20.3% Since SmarTrend Recommendation (RVNC)

By Nick Russo

SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on January 17th, 2019 at $17.33. In approximately 3 months, Revance Therapeu has returned 20.29% as of today's recent price of $13.81.

In the past 52 weeks, shares of Revance Therapeu have traded between a low of $13.63 and a high of $35.05 and are now at $13.81, which is 1% above that low price. Over the past week, the 200-day moving average (MA) has gone down 1.7% while the 50-day MA has declined 1.7%.

Revance Therapeutics, Inc. produces biopharmaceutical products. The Company develops drug delivery and treatments for dermatology and aesthetic medicine. Revance Therapeutics serves patients and doctors throughout the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Revance Therapeu.

Log in and add Revance Therapeu (RVNC) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights revance therapeu

Ticker(s): RVNC